Skip to main content
Log in

Long–term survival of Parkinson's disease

A population–based study

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

In a set of a population– based study, long–term survival of 59 prevalent PD patients was compared with that of individuals free of neurological diseases matched 1:2 by sex and age of enrolment. PD individuals, compared with reference subjects, showed a two–fold increased risk of death (OR 2.1; 95 % CI 1.4, 3.1). Among causes of death, pneumonia and cachexia were significantly more frequent among PD patients than among individuals free of neurological diseases. We confirmed in a long–term follow–up study an increased mortality among PD individuals compared with that of the general population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA (1996) Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People. N Engl J Med 334(2):71–76

    Article  CAS  PubMed  Google Scholar 

  2. Berger K, Breteler MM, Helmer C, Inzitari D, Fratiglioni L, Trenkwalder C, Hofman A, Launer LJ (2000) Prognosis with Parkinson's disease in Europe: A collaborative study of population–based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54(11 Suppl 5):S24–S27

    CAS  PubMed  Google Scholar 

  3. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD (1990) An examination of male–female differences in progression and mortality of Parkinson's disease. Neurology 40(5):763–766

    CAS  PubMed  Google Scholar 

  4. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Besson JA, Mutch WJ (1990) Parkinson's disease in Aberdeen: survival after 3. 5 years. Acta Neurol Scand 81(4):294–299

    CAS  PubMed  Google Scholar 

  5. Elbaz A, Bower JH, Peterson BJ, Maraganore DM, McDowell SK, Ahlskog JE, Shaid DJ, Rocca WA (2003) Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol Jan 60(1):91–96

    Google Scholar 

  6. Herlofson K, Lie SA, . rsland D, Larsen JP (2004) Mortality and Parkinson disease. A community based study. Neurology 62:937–942

    PubMed  Google Scholar 

  7. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR (1996) Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle–aged men. Neurology 46(4):1044–1050

    CAS  PubMed  Google Scholar 

  8. Morgante L, Salemi G, Meneghini F, Di Rosa AE, Epifanio A, Grigoletto F, Ragonese P, Patti F, Reggio A, Di Perri R, Savettieri G (2000) Parkinson disease survival: a population–based study. Arch Neurol 57(4):507–512

    Article  CAS  PubMed  Google Scholar 

  9. Wermuth L, Stenager EN, Stenager E, Boldsen J (1995) Mortality in patients with Parkinson's disease. Acta Neurol Scand Jul 92(1):55–58

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Savettieri MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'Amelio, M., Ragonese, P., Morgante, L. et al. Long–term survival of Parkinson's disease. J Neurol 253, 33–37 (2006). https://doi.org/10.1007/s00415-005-0916-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0916-7

Key words

Navigation